Multiple-center, randomized, open and parallel controlled clinical trial of Nucleoside Analogues: effects and safety on patients with HBV Associated Acute on Chronic Liver Failure.

Trial Profile

Multiple-center, randomized, open and parallel controlled clinical trial of Nucleoside Analogues: effects and safety on patients with HBV Associated Acute on Chronic Liver Failure.

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Apr 2016

At a glance

  • Drugs Entecavir (Primary) ; Lamivudine (Primary)
  • Indications Hepatitis B
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 21 May 2012 Actual end date 31 Oct 2011 added as reported by Chinese Clinical Trial Register.
    • 05 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top